Agios Pharmaceuticals (8AP.F) Q1 2026 Earnings

Feb 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.69
-1.58
-1.48
-1.37

Details

Expected EPS
-1.64607713832
Actual EPS
-1.5671244
Surprise EPS
0.08
Surprise Percent
+4.8%

Description

⁨Agios Pharmaceuticals⁩ (⁦8AP.F⁩) has reported earnings of ⁦-1.5671244⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts